医学
淋巴瘤
弥漫性大B细胞淋巴瘤
突变
病理
肿瘤科
内科学
遗传学
基因
生物
作者
Huili Wang,Chunyu Shang,Wei Hua,Hua Yin,Yue Li,Junheng Liang,Rui Gao,Bihui Pan,Xinyu Zhang,Jia‐Zhu Wu,Hao-Rui Shen,Li Wang,Jianyong Li,Jin‐Hua Liang,Wei Xu
标识
DOI:10.4143/crt.2024.1143
摘要
Our results indicated that CD58mut could serve as a novel prognostic factor for DLBCL patients, and further exploration of personalized treatment strategies for high-risk DLBCL patients based on the risk score model is needed.
科研通智能强力驱动
Strongly Powered by AbleSci AI